GE HealthCare Technologies (GEHC) Income from Non-Controlling Interests (2022 - 2026)
GE HealthCare Technologies' (GEHC) quarterly Income from Non-Controlling Interests came in at $13.0 million in Q2 2026, down 7.14% YoY from $14.0 million in Q2 2025, and down 40.91% on a QoQ basis from $22.0 million in Q1 2026.
GE HealthCare Technologies (GEHC) Income from Non-Controlling Interests (2022 - 2026) Analysis & Trends
GE HealthCare Technologies (GEHC) has 5 years of Income from Non-Controlling Interests data on file, last reported at $13.0 million in Q2 2026.
- Quarterly Income from Non-Controlling Interests fell 7.14% year-over-year to $13.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $66.0 million (down 10.81% YoY) and the FY2025 annual result came in at $70.0 million, up 22.81% from the prior year.
- Income from Non-Controlling Interests declined to $13.0 million in Q2 2026, from $22.0 million in the prior quarter.
- In the past five years, Income from Non-Controlling Interests ranged from a high of $24.0 million in Q1 2025 to a low of $6.0 million in Q3 2022.
- A 5-year average of $14.3 million and a median of $13.5 million in 2022 frame the typical range for Income from Non-Controlling Interests.
- The widest YoY moves for Income from Non-Controlling Interests: up 171.43% in 2024, down 53.33% in 2024.
- Tracing GEHC's Income from Non-Controlling Interests over 5 years: stood at $19.0 million in 2022, then slumped by 31.58% to $13.0 million in 2023, then soared by 30.77% to $17.0 million in 2024, then decreased by 23.53% to $13.0 million in 2025, then changed by 0.0% to $13.0 million in 2026.
- The last three Income from Non-Controlling Interests figures came in at $13.0 million (Q2 2026), $22.0 million (Q1 2026), and $13.0 million (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.54 Bn | 193.94 Bn | 7.27 Bn | - |
| 2 | Stryker | 129.61 Bn | 126.14 Bn | 4.50 Bn | - |
| 3 | Medtronic | 120.10 Bn | 110.88 Bn | 6.41 Bn | 16.00 Mn |
| 4 | Boston Scientific | 74.14 Bn | 73.60 Bn | 3.85 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 52.52 Bn | 48.27 Bn | 1.35 Bn | -500,000.00 |
| 6 | Dexcom | 34.69 Bn | 32.75 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.78 Bn | 31.68 Bn | 2.18 Bn | 13.00 Mn |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | 2.32 Mn |
| 9 | Steris | 23.09 Bn | 22.61 Bn | 684.20 Mn | 900,000.00 |
| 10 | Zimmer Biomet Holdings | 19.37 Bn | 18.96 Bn | 1.54 Bn | 1.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.00 Mn |
| Mar 31, 2026 | 22.00 Mn |
| Dec 31, 2025 | 13.00 Mn |
| Sep 30, 2025 | 18.00 Mn |
| Jun 30, 2025 | 14.00 Mn |
| Mar 31, 2025 | 24.00 Mn |
| Dec 31, 2024 | 17.00 Mn |
| Sep 30, 2024 | 19.00 Mn |
| Jun 30, 2024 | 7.00 Mn |
| Mar 31, 2024 | 14.00 Mn |
| Dec 31, 2023 | 13.00 Mn |
| Sep 30, 2023 | 7.00 Mn |
| Jun 30, 2023 | 15.00 Mn |
| Mar 31, 2023 | 11.00 Mn |
| Dec 31, 2022 | 19.00 Mn |
| Sep 30, 2022 | 6.00 Mn |
| Jun 30, 2022 | 13.00 Mn |
| Mar 31, 2022 | 13.00 Mn |